XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Shareholders' Equity and Share Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Shareholders' Equity and Share Based Compensation | 16. SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION On January 30, 2023, the Company closed a public offering (the "Offering") of 18,350,000 Common Shares at a price of US$1.35 per share together with accompanying warrants to purchase up to 18,350,000 Common Shares, which have an exercise price of US$1.65 per share (the "Warrants"). The gross proceeds from the Offering were approximately US$25 million before deducting placement agent fees and other offering expenses payable by the Company. The proceeds from the Offering are being used for general working capital. The accompanying Warrants have an exercise price of US$1.65 and became exercisable beginning six months from issuance and will expire five years from the date of initial exercisability. On August 9, 2022, Village Farms entered into a Controlled Equity Offering Sales Agreement ("Sales Agreement") pursuant to which the Company may offer and sell Common Shares having an aggregate offering price up to $50 million from time to time to or through Cantor Fitzgerald & Co. and A.G.P./Alliance Global Partners. As of December 31, 2022, the Company had issued and sold 3,175,000 Common Shares under the Sales Agreement, resulting in net proceeds of $6,692 after deducting commissions and offering expenses. The Company’s Share-Based Compensation Plan (the “Plan”) dated January 1, 2010, was most recently approved by Shareholders on June 10, 2021. The Plan provides that the number of Common Shares reserved for issuance upon the exercise or redemption of awards granted under the Plan is a rolling maximum of ten percent (10%) of the outstanding Common Shares at any point in time. Approximately 4,715 shares remain available for issuance as of December 31, 2024. Stock options have been granted with an exercise price equal to the fair market value of the common stock on the date of grants and have a ten-year contractual term. The stock options vest ratably over a 3- year period. Compensation expense is recognized over the vesting period, using the graded vesting method, by increasing additional paid-in capital based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately. The fair market value of stock options is estimated using the Black-Scholes-Merton valuation model and the Company uses the following methods to determine its underlying assumptions: expected volatilities are based on the historical volatilities of the weekly closing price of the Company’s common stock; the expected term of options granted is based historical exercises and forfeitures; the risk-free interest rate is based on Canadian Treasury bonds issued with similar life terms to the expected life of the grant; and the expected dividend yield is based on the current annual dividend amount divided by the stock price on the date of grant. Forfeitures are recorded when incurred. The following key assumptions were used in the valuation model to value stock option grants for each respective period:
|  | 2024 |  | 2023 |  | 2022
Expected volatility |  | 77.2% - 85.8% |  | 85.7% - 87.8% |  | 84.0% - 89.9%
Dividend |  | $nil |  | $nil |  | $nil
Risk-free interest rate |  | 3.08% - 3.71% |  | 2.76% - 4.15% |  | 1.41% - 3.28%
Expected life |  | 4.4 years |  | 6.5 years |  | 6.5 years
Fair value |  | $0.56 - $0.62 |  | $0.44 - $0.82 |  | $0.93 - $4.33
Stock option transactions under the Company’s plan for the years ended December 31, 2024, 2023 and 2022 are summarized as follows:
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2021 |  |  | 3,622,558 |  |  | $ | 6.20 |  |  |  | 7.89 |  |  | $ | 6,530 |
Granted during 2022 |  |  | 725,360 |  |  | $ | 2.74 |  |  |  | 9.70 |  |  | $ | 16 |
Exercised during 2022 |  |  | (180,000 | ) |  | $ | 1.30 |  |  |  | 0.51 |  |  | $ | 772 |
Forfeited during 2022 |  |  | (78,500 | ) |  | $ | 8.45 |  |  |  |  |  |  |
Outstanding at December 31, 2022 |  |  | 4,089,418 |  |  | $ | 5.76 |  |  |  | 6.77 |  |  | $ | 152 |
Exercisable at December 31, 2022 |  |  | 2,549,401 |  |  | $ | 5.88 |  |  |  | 5.46 |  |  | $ | 133 |
Granted during 2023 |  |  | 3,492,991 |  |  | $ | 0.94 |  |  |  | 9.34 |  |  | $ | 130 |
Exercised during 2023 |  |  | (100,000 | ) |  | $ | 0.83 |  |  |  |  |  | $ | 71 |
Forfeited during 2023 |  |  | (535,833 | ) |  | $ | 4.04 |  |  |  |  |  |  |
Outstanding at December 31, 2023 |  |  | 6,946,576 |  |  | $ | 3.50 |  |  |  | 7.54 |  |  | $ | 83 |
Exercisable at December 31, 2023 |  |  | 3,081,262 |  |  | $ | 6.07 |  |  |  | 5.44 |  |  | $ | 1 |
Granted during 2024 |  |  | 170,000 |  |  | $ | 0.95 |  |  |  | 5.96 |  |  | $ | 0 |
Forfeited/expired during 2024 |  |  | (598,167 | ) |  | $ | 3.32 |  |  |  |  |  |  |
Outstanding at December 31, 2024 |  |  | 6,518,409 |  |  | $ | 3.44 |  |  |  | 6.79 |  |  | $ | 90 |
Exercisable at December 31, 2024 |  |  | 4,038,856 |  |  | $ | 4.88 |  |  |  | 5.96 |  |  | $ | 31 |
The weighted-average grant-date fair value of options granted during the years 2024, 2023 and 2022 was $0.58, $0.71 and $3.31, respectively. The total intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022, was $0, $71 and $772, respectively. A summary of the status of the Company’s non-vested stock options, and the changes during the year ended December 31, 2024 is presented below:
|  | Number of Options |  |  | Weighted Average Grant Date Fair Value |  |  | Aggregate Intrinsic Value |
Non-vested at January 1, 2024 |  |  | 3,865,314 |  |  | $ | 1.07 |  |  |  |
Granted |  |  | 170,000 |  |  | $ | 0.58 |  |  |  |
Vested |  |  | (957,594 | ) |  | $ | 0.90 |  |  |  |
Forfeited |  |  | (598,167 | ) |  | $ | 2.27 |  |  |  |
Non-vested at December 31, 2024 |  |  | 2,479,553 |  |  | $ | 0.82 |  |  | $ | 59 |
As of December 31, 2024, there was approximately $2,022 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the stock option plan; that cost is expected to be recognized over a period of three years. The Company has also issued performance-based or time-based restricted share units to Village Farms employees involved with future developments of the Company. Once a performance or time based target is met and the share units are deemed earned and vested, compensation expense is recognized, based on the fair value of the share units on the grant date. Performance-based restricted share unit activity for the years ended December 31, 2024, 2023 and 2022 is as follows:
|  | Number of Performance-based Restricted Share Units |  |  | Weighted Average Grant Date Fair Value |
Outstanding at December 31, 2021 |  |  | 230,000 |  |  | $ | 6.83 |
Exercised |  |  | (200,000 | ) |  | $ | 6.41 |
Outstanding at December 31, 2022 |  |  | 30,000 |  |  | $ | 8.31 |
Exercisable at December 31, 2022 |  |  | 30,000 |  |  | $ | 8.31 |
Issued |  |  | (10,000 | ) |  | $ | 8.31 |
Forfeited |  |  | (20,000 | ) |  | $ | 8.31 |
Outstanding at December 31, 2023 |  |  | — |  |  | $ | 8.31 |
Exercisable at December 31, 2023 |  |  | — |  |  |  | — |
Granted |  |  | 2,179,884 |  |  | $ | 0.71 |
Vested and Issued |  |  | (1,479,024 | ) |  | $ | 1.25 |
Outstanding at December 31, 2024 |  |  | 700,860 |  |  | $ | 0.17 |
Exercisable at December 31, 2024 |  |  | — |  |  | $ | - |
On September 3, 2024, the Company granted 600,000 shares to a director of the Company. Total share-based compensation for the years ended December 31, 2024, 2023 and 2022 of $3,747, $3,111 and $3,987, respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to additional paid in capital.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration